Mark Gurney
Chairman and CEO @Tetra Therapeutics, A Shionogi Group Company
Grand Rapids, MI, US
EMAILS
MOBILE NUMBERS
+91 *********19
Signup · Get unlimited contacts
WORK HISTORY
Nov 2010 — Present
Chairman and CEO @Tetra Therapeutics, A Shionogi Group Company
View department →
Tetra Discovery Partners is a clinical stage company focused on bringing clarity of thought to people suffering from Alzheimer\'s Disease, Fragile X syndrome, Traumatic Brain Injury, and Schizophrenia. Tetra drugs selectively target isoforms of phosphodiesterase 4 (PDE4) including PDE4B and PDE4D.
EDUCATION
1990 — 1994
Northwestern University - Kellogg School of Management
MBA, Business
1976 — 1980
Caltech
PhD, Neuroscience
ABOUT MARK GURNEY
Chairman and CEO / Tetra Discovery Partners
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.